Book a demo

Endoscopic Instrument Patents: Who Leads, Where the Gaps Are 2026

Endoscopic Instrument Patents: Who Leads, Where the Gaps Are 2026
https://www.patsnap.com/resources/blog/rd-blog/endoscopic-instruments-and-single-use-endoscopes-patent-landscape/ · Patsnap · data cut-off 2026-07-31 · downloaded from the live page
Patent Landscape · Medical Equipment
Endoscopic Instruments and Single-Use Endoscopes: Patents Behind the Field
  • 43.6% concentration. The top 5 of 55 ranked assignees hold 95 of 218 records in scope — nearly half the field sits with a handful of filers.
  • Filing has cooled since 2019. Volume peaked at 12 records that year and has declined toward 1 in the most recent (partial) year, with the 2022 midpoint already back to 6.
  • Claim space is narrow outside A61B. Every record in scope carries an A61B class; only optics (G02B, 6.4%) and fluid-handling (A61M, 6.9%) show meaningful secondary activity.
Get a prior-art report on your approach
218
Published Records
44%
Top-5 Share of All Records
-33%
3-Yr Growth (lag-adjusted)
US
Leading Jurisdiction
Published byPatsnap Research··7 min readSourced from Patsnap Eureka
Overview

What this dataset covers

This landscape draws on 218 published records filed between 2015 and mid-2026 that combine endoscopic instrument or single-use/disposable endoscope terminology with claim language around cross-contamination risk, image quality versus cost trade-offs, articulation, sterilization avoidance, or environmental footprint, restricted to A61B1, H04N23 and A61B17 classifications. That combination targets the specific commercial tension in this field: reusable, high-image-quality endoscopic instruments carry sterilization and cross-contamination cost, while single-use designs trade some of that away for disposability and simpler compliance.

Because publication lags filing by roughly 18 months, the most recent year of the trend understates real activity; treat 2025 and 2026 figures as a floor, not a ceiling. Family counts, not raw document counts, are used throughout the ranking so that multi-jurisdiction filing by a single applicant does not inflate its apparent share.

Filing activity and technology composition, 2017–2026
  1. 1COVIDIEN LP25
  2. 2ETHICON INC19
  3. 3KARL STORZ SE & CO KG19
  4. 4INTERSCOPE INC17
  5. 5BOSTON SCIENTIFIC SCIMED INC15
  6. 6INTUITIVE SURGICAL OPERATIONS INC15
  7. 7RICHARD WOLF GMBH13
  8. 8ETHICON ENDO SURGERY INC12
  9. 9GYRUS MEDICAL LTD11
  10. 10IPG PHOTONICS CORP7
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Endoscopic Instruments and Single-Use Endoscopes covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
The Numbers

Filing trend and technology composition

Two views of the same 218 records: how filing volume has moved year over year, and which IPC subclasses the claims actually sit in.

Filing trend, 2017–2026

Filings ran at 10 in 2017, rose to a peak of 12 in 2019, and had fallen back to 6 by the 2022 midpoint, continuing to decline toward 1 in the most recent (partial) year — a flat-to-declining pattern rather than a growth curve.

Filing trend, 2017–2026036912102017201812201920202021202220232024202512026Most recent year is partial — publication lag means later filings are not yet visible.

IPC subclass composition

Every record in scope carries an A61B classification (100.0% of 218), confirming the search scope. Beyond that base, secondary activity clusters in body-fluid devices (A61M, 6.9%) and optical systems (G02B, 6.4%), with implants (A61F, 1.8%), robotic manipulators (B25J, 1.4%) and sterilising equipment (A61L, 0.5%) each covering a narrow slice. Since a record can carry several classes, these shares sum to more than 100% of the 218-record base.

IPC subclass compositionA61B · Diagnosis & surgery218100.0%A61M · Devices for body fluids156.9%G02B · Optical elements & systems146.4%A61F · Implants & prostheses41.8%B25J · Manipulators & robots31.4%A61L · Sterilising & disinfecting10.5%

Shares are the percentage of the 218 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Endoscopic Instruments and Single-Use Endoscopes covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Endoscopic Instruments and Single-Use Endoscopes with Eureka

This page is one run against one query. Ask Eureka your own question about endoscopic instruments and single-use endoscopes and every answer comes back with the patent numbers behind it.

Try Eureka
Key Patents

Representative and most-cited filings

Representative Filing
US8114017B22012-02-14

US8114017B2 — Articulating endoscopic instrument (Karl Storz, 2012-02-14)

KARL STORZ SE & CO. KG

An endoscopic instrument comprises a shaft with proximal and distal ends. A grip with a handle sits at the proximal end; a tool with open and closed positions sits at the distal end. The shaft has two sections, the second of which articulates relative to the first and carries the tool. An actuating element connects the handle to the second section and initiates articulation of that section.Abstract trimmed for length; see the full record for complete claim language.

US8114017B2 — patent drawing 1US8114017B2 — patent drawing 2
View full record
Most-cited records in scope
#Publication no.Patent titleCitations
1US5792165AEndoscopic instrument with detachable end effector2,776
2US5330502ARotational endoscopic mechanism with jointed drive mechanism2,657
3US5405344AArticulable socket joint assembly for an endoscopic instrument for surgical fastner track therefor2,224
4US5368015AAutomated surgical system and apparatus2,179
5US5501654AEndoscopic instrument having articulating element2,173
6US5275608AGeneric endoscopic instrument2,053
7US8603135B2Articulating surgical apparatus1,422
8US8114017B2Articulating endoscopic instrument969
9EP0646356A2Articulable socket joint assembly for an endoscopic instrument and surgical fastener track therefor956
10US6019780ADual pin and groove pivot for micro-instrument628

Citation counts favour older filings simply because they have had longer to accumulate citations inside this corpus; read them as a signal of influence on subsequent drafting, not as a measure of current commercial relevance.

Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Endoscopic Instruments and Single-Use Endoscopes covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis

 
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Insights

What the data means for a filing decision

Three findings that should shape where a new filing targets claim space in this field.

Concentration
43.6% / 218
top 5 share of records in scope

The lead group has room, the middle does not

With 95 of 218 records held by the top 5 of 55 ranked assignees, and the leader alone holding 25, new entrants face dense prior art wherever those assignees have already claimed articulation and end-effector mechanics. The long tail below tenth place (7 records) suggests single-filing entrants still find room at the margins.

Read against the assignee ranking table.
Momentum
12 → 1
peak (2019) to latest partial year

Filing has cooled, not accelerated

Volume peaked in 2019 and has declined through the 2022 midpoint of 6 toward a single record in the latest partial year. Several of the most active named assignees show zero filings in the latest year tracked, consistent with a maturing rather than expanding claim landscape.

Publication lag means the last one to two years will revise upward.
Technology mix
6.9% / 6.4%
A61M and G02B share of 218 records

Secondary claim space is thin

Beyond the universal A61B base, only fluid-handling (A61M) and optics (G02B) show more than a handful of records, at 6.9% and 6.4% of 218 respectively. Implants, robotic manipulation and sterilising equipment each sit under 2%, marking them as comparatively open branches rather than crowded ones.

Shares sum above 100% because records carry multiple IPC codes.
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to endoscopic instruments and single-use endoscopes, with the prior art for and against each one.

Find the white space →
Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Endoscopic Instruments and Single-Use Endoscopes covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Players

Who is filing, and where the gate sits

The ranking behind this page covers 55 companies, counted in families, not a top-50 or top-100 cut. It is worth reading the concentration numbers alongside the recent-year momentum, because several of the largest historical filers show no activity in the latest year tracked.

Leader
25 records
leading assignee

A single filer holds the largest single share

The leading assignee's 25 records sit well ahead of fifth place at 15, but even that leading share is a minority of the 218-record field — no single company controls the space outright.

Compare against the top 5 combined share of 43.6%.
Mid-tier
15 → 7
fifth to tenth place

A tight mid-tier, then a drop-off

Fifth place holds 15 records and tenth place holds 7 — roughly half the leading position's count. The top 10 combined account for 70.2% of all 218 records, leaving a long tail of smaller and single-filing entrants to split the remainder.

See the full ranking table for the names behind these positions.
Collaboration
4 pairs
co-assignee pairings identified

Co-filing is rare, not structural

Only four co-assignee pairs appear across the dataset, the strongest linking a major scope manufacturer with a named inventor on two records. This is a field of independent corporate filers rather than joint-venture or cross-licensed development.

Useful context when assessing freedom-to-operate risk from alliances.
🔍
Under-claimed sub-areas worth checking before filing
Branches where IPC coverage is thin relative to the A61B base — worth a freedom-to-operate check before assuming the space is open.
Sterilisation-avoidance mechanisms (A61L)Robotic-assisted articulation (B25J)Single-use optical channel design (G02B)Body-fluid management integration (A61M)Implant-compatible endoscopic tooling (A61F)
Rank all filers by momentum →
Recent-year filing momentum by assignee
AssigneeRecent yearYoY
Ethicon Endo-Surgery, Inc.0
Covidien LP0
Interscope, Inc.0
Intuitive Surgical Operations, Inc.0
Richard Wolf GmbH0
Boston Scientific Scimed, Inc.0
Karl Storz SE & Co. KG0-100%
Gyrus Medical Ltd.0
Source: Patsnap Eureka. Assignee-level momentum. Derived from a Patsnap search on Endoscopic Instruments and Single-Use Endoscopes covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
What's Next

Where to take this analysis

The figures on this page are a starting point for a freedom-to-operate check or a whitespace filing strategy, not a substitute for one.

Check claim scope against the leading assignees

Before drafting in articulation or end-effector mechanics, review the granted claims held by the top 5 ranked assignees, who together hold 43.6% of the 218 records in scope.

Explore assignee claims in Eureka

Trace the most-cited prior art forward

The most-cited records in this set date back to the 1990s; use forward-citation mapping to see which recent filings build on them before assuming a mechanism is unclaimed.

Run a citation map in Eureka

Test a claim against the under-claimed branches

Sterilisation-avoidance and robotic-assisted articulation both show thin IPC coverage relative to the A61B base — a targeted search will confirm whether that reflects genuine white space or under-indexing.

Search white space in Eureka
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Endoscopic Instruments and Single-Use Endoscopes covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ

Common questions on this landscape

Answers are grounded in the same dataset. Derived from a Patsnap search on Endoscopic Instruments and Single-Use Endoscopes covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Endoscopic Instruments and Single-Use Endoscopes in depth with Eureka

Go past this page: query the whole endoscopic instruments and single-use endoscopes corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.